Clifford Chance advises Otsuka on US$200 million loan financing to MicroPort Scientific
Clifford Chance has advised Otsuka Medical Devices Co., Ltd ("Otsuka" or "the Company") in relation to the US$200 million (approximately HKD1.56 billion) loan financing to MicroPort Scientific Corporation ("MicroPort Scientific") as well as the related purchase option and other commercial arrangements between Otsuka and MicroPort Scientific.
Otsuka engages in the research, development and commercialisation of medical devices. The Company is a wholly-owned subsidiary of Otsuka Holdings Co., Ltd, which is listed on the Tokyo Stock Exchange.